CORAT Therapeutics GmbH
PrivateLast Round
Grant
Jul 13, 2022
Total Funding Raised
$38.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CORAT Therapeutics GmbH operates in Healthcare & Life Sciences and is based in Braunschweig. Its latest recorded funding round was a Grant round in July 2022.
CORAT Therapeutics GmbH is a biopharmaceutical company that develops innovative therapeutic drugs composed of fully human neutralizing antibodies for the treatment of infectious diseases, including COVID-19.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CORAT Therapeutics GmbH Comparables
Compare CORAT Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regeneron Pharmaceuticals | 72% | |
| Celltrion | 70% | |
| AstraZeneca | 70% |
For institutional investors. Book with your work email.
CORAT Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 13, 2022 | ||||
| Strategic | Jul 7, 2021 | ||||
| VC Round | Jun 3, 2021 | ||||
| VC Round | Jan 12, 2021 | ||||
| Seed | Jun 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CORAT Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | VC Round |
| NBank Capital | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 101% MoM.
- Jul 25, 2026
Monthly visitors increased 1335% MoM, from 34 to 488.
For institutional investors. Book with your work email.
CORAT Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CORAT Therapeutics GmbH's valuation, stock price, and market status.
Is CORAT Therapeutics GmbH a public or private company?
CORAT Therapeutics GmbH is a private company.
What is the current stock price of CORAT Therapeutics GmbH?
CORAT Therapeutics GmbH is a private company, so its shares have no public market price. Caplight tracks CORAT Therapeutics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CORAT Therapeutics GmbH worth (valuation)?
Valuation information for CORAT Therapeutics GmbH is not publicly available.
Can I buy CORAT Therapeutics GmbH stock?
CORAT Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CORAT Therapeutics GmbH's last funding round?
CORAT Therapeutics GmbH's most recent funding round was Grant on July 13, 2022.
Who are the main investors in CORAT Therapeutics GmbH?
Key investors in CORAT Therapeutics GmbH include NBank Capital.
Will CORAT Therapeutics GmbH IPO soon?
No public IPO plans have been announced for CORAT Therapeutics GmbH.
How can I track CORAT Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in CORAT Therapeutics GmbH's shares on secondary markets.